We help detect cancer early — so treatment can begin sooner and lives can be saved.

We pride ourselves on delivering reports faster than industry standards. Most of our test results are available within 24–48 hours, depending on the complexity of the panel. Speed matters — and we ensure that timely reports empower both doctors and patients to act quickly.

Not only do we ensure direct delivery of reports, but we also initiate verbal communication for each case with the treating doctor — enabling immediate clinical decisions and personalized care.

Yes. Unlike many larger diagnostic labs that rely on delayed, bureaucratic communication channels, we ensure your doctor receives the report directly and promptly. This reduces wait times, avoids miscommunication, and allows for faster clinical decisions.

Geneflow Labs utilizes cutting-edge technology and innovative molecular techniques to provide accurate and early detection of Leukemia/Lymphoma and other solid cancer, ensuring better treatment outcomes and improved patient care.

Our team is led by Dr. Sachin, who has over 20+ years of experience in hematopathology and molecular oncology. His expertise and leadership ensure the highest standards of diagnostic accuracy and patient care.

We offer a comprehensive range of diagnostic services, including flow cytometry, molecular genetics, cytogenetics, and advanced molecular biology techniques to accurately diagnose and monitor Leukemia/lymphoma and other solid cancer.

Geneflow Labs is continuously updating blood cancer and solid cancer diagnostic panels according to recent update in cancer research and treatment so that most recent and best immunotherapy or targeted therapy can be chosen for the patient.

Geneflow Labs is committed to supporting both patients and healthcare providers by offering detailed diagnostic reports, personalized consultation services, and guidance on the best treatment options based on the latest research and advancements in leukemia care.